Skip to main content
Nasheed Hossain, MD, Hematology, Philadelphia, PA

NasheedMohammadHossainMD

Hematology Philadelphia, PA

Hematologic Oncology

Physician

Dr. Hossain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hossain's full profile

Already have an account?

  • Office

    3400 Spruce St
    Philadelphia, PA 19104
    Phone+1 215-615-0063
    Fax+1 215-349-8144

Education & Training

  • Temple University Hospital-Fox Chase Cancer Center
    Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 2010 - 2013
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 2010

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2016 - 2025
  • PA State Medical License
    PA State Medical License 2013 - 2024
  • IL State Medical License
    IL State Medical License 2018 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Publications & Presentations

PubMed

Abstracts/Posters

  • Detectable Circulating Tumor DNA 28 Days after the CD19 CAR T-Cell Therapy, Axicabtagene Ciloleucel, Is Associated with Poor Outcomes in Patients with Diffuse Large B-...
    Nasheed Hossain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Phase I Trial Using CD19/CD22 Bispecific CAR T Cells in Pediatric and Adult Acute Lymphoblastic Leukemia (ALL)
    Nasheed Hossain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • ‘Exciting’ Research Spotlights CAR-t’s Evolving Role in Blood Cancer Treatment
    ‘Exciting’ Research Spotlights CAR-t’s Evolving Role in Blood Cancer TreatmentFebruary 22nd, 2023
  • Graft Versus Host Disease Research
    Graft Versus Host Disease ResearchJune 17th, 2023
  • Research into Graft Versus Host Disease (GVHD)
    Research into Graft Versus Host Disease (GVHD)June 28th, 2023